Al-Diwani, AAJ, Pollak, TA, Irani, SR and Lennox, BR (2017) Psychosis: an autoimmune disease? Immunology 152, 388–401.
Andrade, DM, Tai, P, Dalmau, J and Wennberg, R (2011) Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? Neurology 76, 1355–1357.
Armangue, T, Leypoldt, F, Malaga, I, Raspall-Chaure, M, Marti, I, Nichter, C, Pugh, J, Vicente-Rasoamalala, M, Lafuente-Hidalgo, M, Macaya, A, Ke, M, Titulaer, MJ, Hoftberger, R, Sheriff, H, Glaser, C and Dalmau, J (2014) Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Annals of Neurology 75, 317–323.
Armangue, T, Moris, G, Cantarin-Extremera, V, Conde, CE, Rostasy, K, Erro, ME, Portilla-Cuenca, JC, Turon-Vinas, E, Malaga, I, Munoz-Cabello, B, Torres-Torres, C, Llufriu, S, Gonzalez-Gutierrez-Solana, L, Gonzalez, G, Casado-Naranjo, I, Rosenfeld, M, Graus, F and Dalmau, J (2015). Autoimmune post-herpes simplex encephalitis of adults and teenagers. Neurology 85, 1736–1743.
Baizabal-Carvallo, JF and Jankovic, J (2018) Autoimmune and paraneoplastic movement disorders: an update. Journal of the Neurological Sciences 385, 175–184.
Baysal-Kirac, L, Tuzun, E, Altindag, E, Ekizoglu, E, Kinay, D, Bilgic, B, Tekturk, P and Baykan, B (2016) Are there any specific EEG findings in autoimmune epilepsies? Clinical EEG and Neuroscience 47, 224–234.
Bernal, F, Graus, F, Pifarre, A, Saiz, A, Benyahia, B and Ribalta, T (2002) Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathologica 103, 509–515.
Bien, CG, Vincent, A, Barnett, MH, Becker, AJ, Blumcke, I, Graus, F, Jellinger, KA, Reuss, DE, Ribalta, T, Schlegel, J, Sutton, I, Lassmann, H and Bauer, J (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135(Pt 5), 1622–1638.
Boronat, A, Sabater, L, Saiz, A, Dalmau, J and Graus, F (2011) GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology 76, 795–800.
Brimberg, L, Benhar, I, Mascaro-Blanco, A, Alvarez, K, Lotan, D, Winter, C, Klein, J, Moses, AE, Somnier, FE, Leckman, JF, Swedo, SE, Cunningham, MW and Joel, D (2012) Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 37, 2076–2087.
Chefdeville, A, Treilleux, I, Mayeur, M-E, Couillault, C, Picard, G, Bost, C, Mokhtari, K, Vasiljevic, A, Meyronet, D, Rogemond, V, Psimaras, D, Dubois, B, Honnorat, J and Desestret, V (2019) Immunopathological characterization of ovarian teratomas associated with anti-N-methyl-D-aspartate receptor encephalitis. Acta Neuropathologica Communications 7, 38.
Chen, X, Liu, F, Li, JM, Xie, XQ, Wang, Q, Zhou, D and Shang, H (2017) Encephalitis with antibodies against the GABAB receptor: seizures as the most common presentation at admission. Neurological Research 39, 973–980.
Coyle, JT, Tsai, G and Goff, D (2003) Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Annals of the New York Academy of Sciences 1003, 318–327.
Cui, J, Bu, H, He, J, Zhao, Z, Han, W, Gao, R, Li, X, Li, Q, Guo, X and Zou, Y (2018) The gamma-aminobutyric acid-B receptor (GABAB) encephalitis: clinical manifestations and response to immunotherapy. International Journal of Neuroscience 128, 627–633.
Dahm, L, Ott, C, Steiner, J, Stepniak, B, Teegen, B, Saschenbrecker, S, Hammer, C, Borowski, K, Begemann, M, Lemke, S, Rentzsch, K, Probst, C, Martens, H, Wienands, J, Spalletta, G, Weissenborn, K, Stocker, W and Ehrenreich, H (2014) Seroprevalence of autoantibodies against brain antigens in health and disease. Annals of Neurology 76, 82–94.
Dale, RC, Merheb, V, Pillai, S, Wang, D, Cantrill, L, Murphy, TK, Ben-Pazi, H, Varadkar, S, Aumann, TD, Horne, MK, Church, AJ, Fath, T and Brilot, F (2012) Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 135(Pt 11), 3453–3468.
Dalmau, J, Geis, C and Graus, F (2017) Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiological Reviews 97, 839–887.
Dalmau, J, Gleichman, AJ, Hughes, EG, Rossi, JE, Peng, X, Lai, M, Dessain, SK, Rosenfeld, MR, Balice-Gordon, R and Lynch, DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurology 7, 1091–1098.
Dalmau, J and Graus, F (2018) Antibody-mediated encephalitis. New England Journal of Medicine 378, 840–851.
Dalmau, J, Graus, F, Villarejo, A, Posner, JB, Blumenthal, D, Thiessen, B, Saiz, A, Meneses, P and Rosenfeld, MR (2004) Clinical analysis of anti-Ma2-associated encephalitis. Brain 127(Pt 8), 1831–1844.
Dalmau, J, Lancaster, E, Martinez-Hernandez, E, Rosenfeld, MR and Balice-Gordon, R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurology 10, 63–74.
Dalmau, J, Tuzun, E, Wu, HY, Masjuan, J, Rossi, JE, Voloschin, A, Baehring, JM, Shimazaki, H, Koide, R, King, D, Mason, W, Sansing, LH, Dichter, MA, Rosenfeld, MR and Lynch, DR (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Annals of Neurology 61, 25–36.
Darnell, RB and Posner, JB (2003) Paraneoplastic syndromes involving the nervous system. New England Journal of Medicine 349, 1543–1554.
De Witte, LD, Hoffmann, C, Van Mierlo, HC, Titulaer, MJ, Kahn, RS and Martinez-Martinez, P (2015) Absence of N-methyl-D-aspartate receptor IgG autoantibodies in schizophrenia: the importance of cross-validation studies. JAMA Psychiatry 72, 731–733.
Dogan Onugoren, M, Deuretzbacher, D, Haensch, CA, Hagedorn, HJ, Halve, S, Isenmann, S, Kramme, C, Lohner, H, Melzer, N, Monotti, R, Presslauer, S, Schabitz, WR, Steffanoni, S, Stoeck, K, Strittmatter, M, Stogbauer, F, Trinka, E, Von Oertzen, TJ, Wiendl, H, Woermann, FG and Bien, CG (2015) Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. Journal of Neurology, Neurosurgery and Psychiatry 86, 965–972.
Finke, C, Kopp, UA, Scheel, M, Pech, LM, Soemmer, C, Schlichting, J, Leypoldt, F, Brandt, AU, Wuerfel, J, Probst, C, Ploner, CJ, Pruss, H and Paul, F (2013) Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Annals of Neurology 74(2), 284–296.
Gable, MS, Gavali, S, Radner, A, Tilley, DH, Lee, B, Dyner, L, Collins, A, Dengel, A, Dalmau, J and Glaser, CA (2009) Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. European Journal of Clinical Microbiology and Infectious Diseases 28, 1421–1429.
Gable, MS, Sheriff, H, Dalmau, J, Tilley, DH and Glaser, CA (2012) The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clinical Infectious Diseases 54, 899–904.
Granerod, J, Ambrose, HE, Davies, NW, Clewley, JP, Walsh, AL, Morgan, D, Cunningham, R, Zuckerman, M, Mutton, KJ, Solomon, T, Ward, KN, Lunn, MP, Irani, SR, Vincent, A, Brown, DW and Crowcroft, NS (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infectious Diseases 10, 835–844.
Graus, F, Boronat, A, Xifro, X, Boix, M, Svigelj, V, Garcia, A, Palomino, A, Sabater, L, Alberch, J and Saiz, A (2010) The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology 74, 857–859.
Graus, F, Titulaer, MJ, Balu, R, Benseler, S, Bien, CG, Cellucci, T, Cortese, I, Dale, RC, Gelfand, JM, Geschwind, M, Glaser, CA, Honnorat, J, Hoftberger, R, Iizuka, T, Irani, SR, Lancaster, E, Leypoldt, F, Pruss, H, Rae-Grant, A, Reindl, M, Rosenfeld, MR, Rostasy, K, Saiz, A, Venkatesan, A, Vincent, A, Wandinger, KP, Waters, P and Dalmau, J (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurology 15, 391–404.
Gresa-Arribas, N, Titulaer, MJ, Torrents, A, Aguilar, E, Mccracken, L, Leypoldt, F, Gleichman, AJ, Balice-Gordon, R, Rosenfeld, MR, Lynch, D, Graus, F and Dalmau, J (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurology 13, 167–177.
Guan, HZ, Ren, HT, Yang, XZ, Lu, Q, Peng, B, Zhu, YC, Shao, XQ, Hu, YQ, Zhou, D and Cui, LY (2015) Limbic encephalitis associated with anti-gamma-aminobutyric acid B receptor antibodies: a case series from China. Chinese Medical Journal 128, 3023–3028.
Hammer, C, Stepniak, B, Schneider, A, Papiol, S, Tantra, M, Begemann, M, Siren, AL, Pardo, LA, Sperling, S, Mohd Jofrry, S, Gurvich, A, Jensen, N, Ostmeier, K, Luhder, F, Probst, C, Martens, H, Gillis, M, Saher, G, Assogna, F, Spalletta, G, Stocker, W, Schulz, TF, Nave, KA and Ehrenreich, H (2014) Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Molecular Psychiatry 19, 1143–1149.
Heine, J, Pruss, H, Bartsch, T, Ploner, CJ, Paul, F and Finke, C (2015) Imaging of autoimmune encephalitis - relevance for clinical practice and hippocampal function. Neuroscience 309, 68–83.
Herken, J and Pruss, H (2017) Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients. Frontiers in Psychiatry 8, 25.
Höftberger, R, Titulaer, MJ, Sabater, L, Dome, B, Rozsas, A, Hegedus, B, Hoda, MA, Laszlo, V, Ankersmit, HJ, Harms, L, Boyero, S, De Felipe, A, Saiz, A, Dalmau, J and Graus, F (2013) Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81, 1500–1506.
Höftberger, R, Van Sonderen, A, Leypoldt, F, Houghton, D, Geschwind, M, Gelfand, J, Paredes, M, Sabater, L, Saiz, A, Titulaer, MJ, Graus, F and Dalmau, J (2015) Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology 84, 2403–2412.
Irani, SR, Alexander, S, Waters, P, Kleopa, KA, Pettingill, P, Zuliani, L, Peles, E, Buckley, C, Lang, B and Vincent, A (2010a) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133, 2734–2748.
Irani, SR, Bera, K, Waters, P, Zuliani, L, Maxwell, S, Zandi, MS, Friese, MA, Galea, I, Kullmann, DM, Beeson, D, Lang, B, Bien, CG and Vincent, A (2010b) N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133(Pt 6), 1655–1667.
Irani, SR, Michell, AW, Lang, B, Pettingill, P, Waters, P, Johnson, MR, Schott, JM, Armstrong, RJ, Zagami, AS, Bleasel, A, Somerville, ER, Smith, SM and Vincent, A (2011). Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Annals of Neurology 69, 892–900.
Jezequel, J, Johansson, EM, Dupuis, JP, Rogemond, V, Grea, H, Kellermayer, B, Hamdani, N, Le Guen, E, Rabu, C, Lepleux, M, Spatola, M, Mathias, E, Bouchet, D, Ramsey, AJ, Yolken, RH, Tamouza, R, Dalmau, J, Honnorat, J, Leboyer, M and Groc, L (2017) Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients. Nature Communications 8, 1791.
Jones, CA, Watson, DJ and Fone, KC (2011) Animal models of schizophrenia. British Journal of Pharmacology 164, 1162–1194.
Kegel, L, Aunin, E, Meijer, D and Bermingham, JR (2013) LGI proteins in the nervous system. ASN Neuro 5, 167–181.
Kim, TJ, Lee, ST, Shin, JW, Moon, J, Lim, JA, Byun, JI, Shin, YW, Lee, KJ, Jung, KH, Kim, YS, Park, KI, Chu, K and Lee, SK (2014) Clinical manifestations and outcomes of the treatment of patients with GABAB encephalitis. Journal of Neuroimmunology 270, 45–50.
Kruer, MC, Hoeftberger, R, Lim, KY, Coryell, JC, Svoboda, MD, Woltjer, RL and Dalmau, J (2014) Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of gamma-aminobutyric acid type B receptor autoimmunity. JAMA Neurology 71, 620–623.
Kuppuswamy, PS, Takala, CR and Sola, CL (2014) Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions. General Hospital Psychiatry 36, 388–391.
Lai, M, Hughes, EG, Peng, X, Zhou, L, Gleichman, AJ, Shu, H, Mata, S, Kremens, D, Vitaliani, R, Geschwind, MD, Bataller, L, Kalb, RG, Davis, R, Graus, F, Lynch, DR, Balice-Gordon, R and Dalmau, J (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Annals of Neurology 65, 424–434.
Lai, M, Huijbers, MG, Lancaster, E, Graus, F, Bataller, L, Balice-Gordon, R, Cowell, JK and Dalmau, J (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurology 9, 776–785.
Lancaster, E (2016) The diagnosis and treatment of autoimmune encephalitis. Journal of Clinical Neurology 12, 1–13.
Lancaster, E and Dalmau, J (2012) Neuronal autoantigens – pathogenesis, associated disorders and antibody testing. Nature Reviews Neurology 8, 380–390.
Lancaster, E, Lai, M, Peng, X, Hughes, E, Constantinescu, R, Raizer, J, Friedman, D, Skeen, MB, Grisold, W, Kimura, A, Ohta, K, Iizuka, T, Guzman, M, Graus, F, Moss, SJ, Balice-Gordon, R and Dalmau, J (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurology 9, 67–76.
Lee, EM, Kang, JK, Oh, JS, Kim, JS, Shin, YW and Kim, CY (2014) 18F-fluorodeoxyglucose positron-emission tomography findings with anti-N-methyl-D-aspartate receptor encephalitis that showed variable degrees of catatonia: three cases report. Journal of Epilepsy Research 4, 69–73.
Lee, WJ, Lee, ST, Moon, J, Sunwoo, JS, Byun, JI, Lim, JA, Kim, TJ, Shin, YW, Lee, KJ, Jun, JS, Lee, HS, Kim, S, Park, KI, Jung, KH, Jung, KY, Kim, M, Lee, SK and Chu, K (2016) Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study. Neurotherapeutics 13, 824–832.
Lim, JA, Lee, ST, Moon, J, Jun, JS, Park, BS, Byun, JI, Sunwoo, JS, Park, KI, Jung, KH, Jung, KY, Lee, SK and Chu, K (2016) New feasible treatment for refractory autoimmune encephalitis: low-dose interleukin-2. Journal of Neuroimmunology 299, 107–111.
Linnoila, JJ, Binnicker, MJ, Majed, M, Klein, CJ and Mckeon, A (2016) CSF herpes virus and autoantibody profiles in the evaluation of encephalitis. Neurology: Neuroimmunology & Neuroinflammation 3, e245.
Lodge, D and Mercier, MS (2015) Ketamine and phencyclidine: the good, the bad and the unexpected. British Journal of Pharmacology 172, 4254–4276.
Mackay, MAB, Kravtsenyuk, M, Thomas, R, Mitchell, ND, Dursun, SM and Baker, GB (2019) D-serine: potential therapeutic agent and/or biomarker in schizophrenia and depression?. Frontiers in Psychiatry 10, 25.
Mantere, O, Saarela, M, Kieseppa, T, Raij, T, Mantyla, T, Lindgren, M, Rikandi, E, Stoecker, W, Teegen, B and Suvisaari, J (2018) Anti-neuronal anti-bodies in patients with early psychosis. Schizophrenia Research 192, 404–407.
Masdeu, JC, Gonzalez-Pinto, A, Matute, C, Ruiz De Azua, S, Palomino, A, De Leon, J, Berman, KF and Dalmau, J (2012). Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. American Journal of Psychiatry 169, 1120–1121.
Moghaddam, B and Javitt, D (2011) From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37, 4.
Morbelli, S, Djekidel, M, Hesse, S, Pagani, M and Barthel, H (2016) Role of (18)F-FDG-PET imaging in the diagnosis of autoimmune encephalitis. Lancet Neurology 15, 1009–1010.
Nosadini, M, Mohammad, SS, Corazza, F, Ruga, EM, Kothur, K, Perilongo, G, Frigo, AC, Toldo, I, Dale, RC and Sartori, S (2017) Herpes simplex virus-induced anti-N-methyl-D-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Developmental Medicine and Child Neurology 59, 796–805.
Oldham, M (2017) Autoimmune encephalopathy for psychiatrists: when to suspect autoimmunity and what to do next. Psychosomatics 58, 228–244.
Pathmanandavel, K, Starling, J, Merheb, V, Ramanathan, S, Sinmaz, N, Dale, RC and Brilot, F (2015) Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children. Biological Psychiatry 77, 537–547.
Pearlman, DM and Najjar, S (2014) Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. Schizophrenia Research 157, 249–258.
Peer, M, Pruss, H, Ben-Dayan, I, Paul, F, Arzy, S and Finke, C (2017) Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study. Lancet Psychiatry 4, 768–774.
Peng, X, Hughes, e.g.Moscato, EH, Parsons, TD, Dalmau, J and Balice-Gordon, RJ (2015) Cellular plasticity induced by anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Annals of Neurology 77, 381–398.
Probasco, JC, Solnes, L, Nalluri, A, Cohen, J, Jones, KM, Zan, E, Javadi, MS and Venkatesan, A (2017) Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis. Neurology: Neuroimmunology and NeuroInflammation 4, e352.
Pruss, H, Finke, C, Holtje, M, Hofmann, J, Klingbeil, C, Probst, C, Borowski, K, Ahnert-Hilger, G, Harms, L, Schwab, JM, Ploner, CJ, Komorowski, L, Stoecker, W, Dalmau, J and Wandinger, KP (2012) N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Annals of Neurology 72, 902–911.
Quartuccio, N, Caobelli, F, Evangelista, L, Alongi, P, Kirienko, M, De Biasi, V and Cocciolillo, F (2015) The role of PET/CT in the evaluation of patients affected by limbic encephalitis: a systematic review of the literature. Journal of Neuroimmunology 284, 44–48.
Rhoads, J, Guirgis, H, Mcknight, C and Duchemin, AM (2011) Lack of anti-NMDA receptor autoantibodies in the serum of subjects with schizophrenia. Schizophrenia Research 129, 213–214.
Riedmuller, R and Muller, S (2017) Ethical implications of the mild encephalitis hypothesis of schizophrenia. Frontiers in Psychiatry 8, 38.
Shin, YW, Lee, ST, Park, KI, Jung, KH, Jung, KY, Lee, SK and Chu, K (2018) Treatment strategies for autoimmune encephalitis. Therapeutic Advances in Neurological Disorders 11, 1–19.
Shin, YW, Lee, ST, Shin, JW, Moon, J, Lim, JA, Byun, JI, Kim, TJ, Lee, KJ, Kim, YS, Park, KI, Jung, KH, Lee, SK and Chu, K (2013) VGKC-complex/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. Journal of Neuroimmunology 265, 75–81.
Solimena, M, Folli, F, Aparisi, R, Pozza, G and De Camilli, P (1990) Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. New England Journal of Medicine 322, 1555–1560.
Solnes, LB, Jones, KM, Rowe, SP, Pattanayak, P, Nalluri, A, Venkatesan, A, Probasco, JC and Javadi, MS (2017) Diagnostic value of (18)F-FDG PET/CT versus MRI in the setting of antibody-specific autoimmune encephalitis. Journal of Nuclear Medicine 58, 1307–1313.
Steiner, J, Walter, M, Glanz, W, Sarnyai, Z, Bernstein, HG, Vielhaber, S, Kastner, A, Skalej, M, Jordan, W, Schiltz, K, Klingbeil, C, Wandinger, KP, Bogerts, B and Stoecker, W (2013) Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry 70, 271–278.
Su, M, Xu, D and Tian, R (2015) 18F-FDG PET/CT and MRI findings in a patient with anti-GABA(B) receptor encephalitis. Clinical Nuclear Medicine 40, 515–517.
Titulaer, MJ, Mccracken, L, Gabilondo, I, Armangue, T, Glaser, C, Iizuka, T, Honig, LS, Benseler, SM, Kawachi, I, Martinez-Hernandez, E, Aguilar, E, Gresa-Arribas, N, Ryan-Florance, N, Torrents, A, Saiz, A, Rosenfeld, MR, Balice-Gordon, R, Graus, F and Dalmau, J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurology 12, 157–165.
Tofaris, GK, Irani, SR, Cheeran, BJ, Baker, IW, Cader, ZM and Vincent, A (2012) Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis. Neurology 79, 195–196.
Tsutsui, K, Kanbayashi, T, Tanaka, K, Boku, S, Ito, W, Tokunaga, J, Mori, A, Hishikawa, Y, Shimizu, T and Nishino, S (2012) Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry 12, 37.
Tuzun, E and Dalmau, J (2007) Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 13, 261–271.
Van Elst, LT, Kloppel, S and Rauer, S (2011) Voltage-gated potassium channel/LGI1 antibody-associated encephalopathy may cause brief psychotic disorder. Journal of Clinical Psychiatry 72, 722–723.
Venkatesan, A and Adatia, K (2017) Anti-NMDA-receptor encephalitis: from bench to clinic. ACS Chemical Neuroscience 8, 2586–2595.
Zandi, MS, Irani, SR, Lang, B, Waters, P, Jones, PB, Mckenna, P, Coles, AJ, Vincent, A and Lennox, BR (2011) Disease-relevant autoantibodies in first episode schizophrenia. Journal of Neurology 258, 686–688.